Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CA5A | P35218 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | HSD11B1 | P28845 | 2/20 | 0.37 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | MGLL | Q99685 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA7 | P43166 | 1/20 | 0.34 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5017164 | 0.81 | PTPN1 (0.40) | CA1CA2CA5ACA9HSD11B1 | |
| SCHEMBL2992202 | 0.79 | CA1 (0.35) | CA1CA2CA5ACA9HSD11B1 | |
| Lithium Ion SCHEMBL5015182 | 0.79 | GPR3 (0.39) | CA1CA2CA5ACA9HSD11B1 | |
| SCHEMBL13266199 | 0.75 | PTGS1 (0.44) | CA1CA2CA5ACA9SMN1; SMN2 | |
| Lithium SCHEMBL2991326 | 0.74 | PTGS1 (0.43) | CA1CA2CA5ACA9SMN1; SMN2 | |
| SCHEMBL2988178 | 0.71 | CA2 (0.50) | CA1CA2CA9MAPTCA12 | |
| SCHEMBL777056 | 0.71 | ALDH1A1 (0.56) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL5013864 | 0.69 | PTPN1 (0.38) | CA1CA2CA5ACA9HSD11B1 | |
| SCHEMBL431548 | 0.69 | MAPT (0.43) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 | |
| SCHEMBL9338259 | 0.69 | SMN1; SMN2 (0.43) | MAPTHPGDSMN1; SMN2MGLLHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2084166-B1 | PREPARATION PROCESS OF AROMATIC SULFONYLIMIDES | INST NAT POLYTECHNIQUE DE GRENOBLE (FR) | 2017-11-22 | — | — | EP | disclosed |
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-8853448-B2 | Aromatic sulfonylimides, preparation thereof and use thereof as electrolyte | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2014-10-07 | — | — | US | disclosed |
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2010-07-08 | — | — | US | disclosed |
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | INSTITUT NATIONAL POLYTECHNIQUE DE GRENOBLE (FR) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174113-A1 | AROMATIC SULPHONYLIMIDES, PREPARATION THEREOF AND USE THEREOF AS ELECTROLYTE | AFF2, ARSA, FGFR2 | CA1 1507/4885CA2 173/4885CA5A 2467/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.